A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.

Sponsor
Zimmer Biomet (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04931056
Collaborator
(none)
40
1
14.9
2.7

Study Details

Study Description

Brief Summary

This study will address medical devices manufactured by Biomet Microfixation (d.b.a. Zimmer Biomet) designed for fixation and stabilization of the facial and mandibular skeleton.

Condition or Disease Intervention/Treatment Phase
  • Device: Titanium Facial Plates
  • Device: Titanium Mandibular Plates
  • Device: Add-on Condyle
  • Device: HTR-PEKK

Detailed Description

The subject devices are:
  • plates, screws, and primary instruments from the Biomet Microfixation Facial Plating System, including plates to be specifically used in orthognathic procedures

  • plates, screws and primary instruments for the Mandibular Plating System, including and a device intended to temporarily restore the functionality of the temporomandibular joint for patients whose natural condyle has to be resected, subsequent to a tumor ablation ("Add-On Condyle") Additionally, a third device intended for the replacement of bony voids in the facial skeleton will be evaluated in this trial (HTR-PEKK- facial application).

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Clinical Evaluation of Biomet Microfixation Devices Used in Facial & Mandibular Surgical Procedures. Facial Plating System, HTR PEKK (Midface) and Mandibular Plates: A Post Market Clinical Follow-up Study
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Oct 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Facial Plating

Patients undergoing surgical procedures for facial reconstruction for whom Biomet Microfixation titanium plates (or Ti mini plates) were utilized for the repair.

Device: Titanium Facial Plates
The Facial Plating System provides a comprehensive titanium fixation solution for maxillofacial surgery procedures. More than twenty-five different plating options in two systems, the 1.5 mm and 2.0 mm with a variety of instruments, and high torque screws, including meshes, are part of this system. Plates and screws are made of commercially pure titanium per ASTM F-67, Titanium 6Al 4V Alloy per ASTM F-136.
Other Names:
  • Titanium facial mini plates
  • Mandibular Plating

    Patients undergoing surgical procedures for mandibular reconstruction, including TMJ, for whom Biomet Microfixation titanium plates (or Ti mini plates) were utilized for the repair.

    Device: Titanium Mandibular Plates
    The Mandibular Plating System provides a comprehensive titanium fixation solution for mandibular surgical procedures. Several plating options, a variety of instruments, and high torque screws with various plate shapes are part of this system. Plates in the Mandibular Plating System have profiles of various thicknesses. Screws are available in self-tapping, locking and non-locking varieties, and in various sizes between 2.0 mm and 2.3 mm in diameter, and 5 mm to 18 mm in length.
    Other Names:
  • Titanium mandibular mini plates
  • Device: Add-on Condyle
    The Add-On Condyle is intended to be implanted in the human jaw to replace the mandibular condyle to functionally reconstruct the temporomandibular joint on a temporary basis for patients undergoing ablative tumor surgery requiring the removal of the native mandibular condyle. This device is not for permanent implantation, traumatic injuries, or for treatment of temporomandibular joint disease.

    HTR-PEKK (midface)

    Patients undergoing surgical procedures for midface reconstruction using custom-made prostheses manufactured on PEEK material.

    Device: HTR-PEKK
    The HTR-PEKK implants are fabricated from polyether-ketone-ketone (PEKK) via selective laser sintering (SLS), a 3D manufacturing technique. The laser sintering machine builds the implant in layers as dictated from a stereolithographic (STL) file of the approved implant. The HTR-PEKK implants are designed individually for each patient to replace bony voids in the facial anatomy using a patient's own CT imaging data. The implant is made to fill an existing or planned void (where appropriate) using computer-aided design technology for anatomy enhancement, correction of trauma injuries, and/or to correct congenital defects in the craniofacial bone.

    Outcome Measures

    Primary Outcome Measures

    1. Survival of implant at 1 year post operative [1 year]

      Frequency and incidence of clinical and radiological adverse events related to the implantation of the subject device leading to removal

    Secondary Outcome Measures

    1. Infection rate at 30 days post operative [30 days]

      Implant site infection rate

    2. Allergic reaction related to implant material [up to 2 years]

      Clinical and/or pathological assessment of implant allergic reactions leading to removal of the device in the first 2 years post implantation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    1. Males or females

    2. A patient who underwent one or more of the following surgical procedures completed between January 1, 2015 and December 31, 2019, with plates, screws, and or meshes from the Biomet Microfixation Facial Plating System:

    • Repair of a facial fracture

    • Repair of a facial osteotomy

    • Reconstructive procedures of the facial skeleton

    • Revision procedures where other treatments or devices have failed

    1. Available follow-up data at least at 30 days' post-operative
    Exclusion Criteria:
    1. Active or latent infection at the time of implantation

    2. Documented foreign body sensitivity

    3. Patients with limited blood supply, insufficient quantity or quality of bone (e.g., osteomalacia or a bone resorption condition such as Paget's disease, osteoporosis, bone metastasis)

    4. Patients with documented mental or neurologic conditions who were unwilling or incapable of following postoperative care instructions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 San Bernardo Hospital Salta Argentina

    Sponsors and Collaborators

    • Zimmer Biomet

    Investigators

    • Study Director: Mark Sun, PhD, Zimmer Biomet

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zimmer Biomet
    ClinicalTrials.gov Identifier:
    NCT04931056
    Other Study ID Numbers:
    • 0220-02
    First Posted:
    Jun 18, 2021
    Last Update Posted:
    Oct 26, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Zimmer Biomet
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 26, 2021